Yong Fan
Research Subjects
Yong Fan has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Dan Wu
Orthopedics The People's Hospital of Renshou County Renshou Sichuan People's Republic of China
1 shared publication- Gang Liu
Orthopedics The People's Hospital of Renshou County Renshou Sichuan People's Republic of China
1 shared publication Hanlin Lv
Orthopedics The People's Hospital of Renshou County Renshou Sichuan People's Republic of China
1 shared publicationJianwen Liu
Orthopedics The People's Hospital of Renshou County Renshou Sichuan People's Republic of China
1 shared publication- Jianying Li
State Key Laboratory of Electrical Insulation and Power Equipment, Xian Jiaotong University, Xian, China
1 shared publication - Jingjing Cui
Huiying Medical Technology Co., Ltd, Beijing, China
1 shared publication
Latest Publications
- 12 April 2024
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 71 (4) , 940-947
Sensitive osteoarthritis sensing by salt‐induced aggregation and dispersion of gold nanoparticles
Osteoarthritis occurs in any joints, and identification in its earlier stages helps to treat the disease and increase the recovery rate. The radiography method and imaging techniques are traditionally used to identify osteoarthritis. But these methods are expensive, and with the complicated steps. Researchers are working toward developing a highly sensitive biosensor in identifying the osteoarthritis biomarker. This research was focused on developing a C-terminal telopeptide of type II collagen (CTX-II) colorimetric sensor with gold nanoparticle (AuNP) for diagnosing osteoarthritis. Anti-CTX-II was conjugated with AuNP and then added with CTX-II and sodium chloride for the color change. In the presence of CTX-II, antibody releases from AuNP then binds with CTX-II, and the color of AuNP changed to purple. Without the CTX-II, AuNP remains its red color (dispersed). This easier colorimetric assay detected the CTX-II as low as 2 ng/mL on linear regression [y = 0.0131x - 0.0051; R2 = 0.9205]. Furthermore, control performances with the relevant proteins osteopontin, IL-6, and nonimmune antibody failed to change the color confirming the specific identification of CTX-II.
- 12 April 2024
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 71 (4) , 940-947
Sensitive osteoarthritis sensing by salt‐induced aggregation and dispersion of gold nanoparticles
Osteoarthritis occurs in any joints, and identification in its earlier stages helps to treat the disease and increase the recovery rate. The radiography method and imaging techniques are traditionally used to identify osteoarthritis. But these methods are expensive, and with the complicated steps. Researchers are working toward developing a highly sensitive biosensor in identifying the osteoarthritis biomarker. This research was focused on developing a C-terminal telopeptide of type II collagen (CTX-II) colorimetric sensor with gold nanoparticle (AuNP) for diagnosing osteoarthritis. Anti-CTX-II was conjugated with AuNP and then added with CTX-II and sodium chloride for the color change. In the presence of CTX-II, antibody releases from AuNP then binds with CTX-II, and the color of AuNP changed to purple. Without the CTX-II, AuNP remains its red color (dispersed). This easier colorimetric assay detected the CTX-II as low as 2 ng/mL on linear regression [y = 0.0131x - 0.0051; R2 = 0.9205]. Furthermore, control performances with the relevant proteins osteopontin, IL-6, and nonimmune antibody failed to change the color confirming the specific identification of CTX-II.
- 6 December 2023
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 71 (2) , 256-263
High‐sensitivity immunoassay on interdigitated electrode to detect osteoporosis biological marker
Osteoporosis is with porous bones, which refers to a decrease in the bone mineral density and weakens the bones to become brittle. Osteoporosis often progresses without any pain or symptoms until the bone fractures. Monitoring the condition of bone regularly helps to identify the bone that weakens at its earlier stages. In general, radiological techniques have been used to measure bone mineral density, are expensive, and the procedures are complicated. Therefore, researchers are focusing on the alternative method of biomarker quantification to identify bone mineral density. This research work was focused on quantifying the osteoporosis biomarker of C‐terminal telopeptide of type I collagen (CTX‐I) on an interdigitated electrode (IDE) sensor. Gold nanomaterial‐modified anti‐CTX‐I antibody was attached to silica nanomaterial‐decorated IDE and then identified by CTX‐I interaction. Higher immobilization of antibodies was recorded on diamond‐modified IDE through gold nanoparticles, and detected CTX‐I as low as 0.5 pg/mL [y = 1.5507x − 0.9043 R2 = 0.9715], determined on a linear curve at the range 0.5–3.5 ng/mL. Further, specific identification of CTX‐I was confirmed by control performances with osteopontin, IL‐6, and anti‐IgG antibody.
- 6 December 2023
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 71 (2) , 256-263
High‐sensitivity immunoassay on interdigitated electrode to detect osteoporosis biological marker
Osteoporosis is with porous bones, which refers to a decrease in the bone mineral density and weakens the bones to become brittle. Osteoporosis often progresses without any pain or symptoms until the bone fractures. Monitoring the condition of bone regularly helps to identify the bone that weakens at its earlier stages. In general, radiological techniques have been used to measure bone mineral density, are expensive, and the procedures are complicated. Therefore, researchers are focusing on the alternative method of biomarker quantification to identify bone mineral density. This research work was focused on quantifying the osteoporosis biomarker of C‐terminal telopeptide of type I collagen (CTX‐I) on an interdigitated electrode (IDE) sensor. Gold nanomaterial‐modified anti‐CTX‐I antibody was attached to silica nanomaterial‐decorated IDE and then identified by CTX‐I interaction. Higher immobilization of antibodies was recorded on diamond‐modified IDE through gold nanoparticles, and detected CTX‐I as low as 0.5 pg/mL [y = 1.5507x − 0.9043 R2 = 0.9715], determined on a linear curve at the range 0.5–3.5 ng/mL. Further, specific identification of CTX‐I was confirmed by control performances with osteopontin, IL‐6, and anti‐IgG antibody.
- Open Access
- 19 September 2023
- Published by Elsevier in Academic Radiology
- Vol. 31 (3) , 1180-1188
Combining Deep Learning and Radiomics for Automated, Objective, Comprehensive Bone Mineral Density Assessment From Low-Dose Chest Computed Tomography
- 19 September 2023
- Published by Elsevier in Academic Radiology
- Vol. 31 (3) , 1180-1188
Open AccessCombining Deep Learning and Radiomics for Automated, Objective, Comprehensive Bone Mineral Density Assessment From Low-Dose Chest Computed Tomography